Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

UPDATE 2-FTSE 100 jumps as pound falls on doubts over Brexit trade deal

Published 02/12/2020, 10:38
Updated 02/12/2020, 18:00
© Reuters.

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)
* UK first in the world to approve Pfizer vaccine
* British minister says no-deal Brexit possible
* G4S jumps after Canada's GardaWorld increases offer
* FTSE 100 up 1.2%, FTSE 250 up 0.2%

(Adds comments, updates prices throughout)
By Shreyashi Sanyal
Dec 2 (Reuters) - The exporter-laden FTSE 100 index jumped
on Wednesday as the sterling weakened on doubts of whether a
trade deal could be reached by Britain and the European Union,
while the UK's approval of a COVID-19 vaccine also supported
sentiment.
The index .FTSE gained 1.2%, while the domestically
focussed mid-cap FTSE 250 .FTMC , considered a barometer for
Brexit sentiment, only edged up 0.2%.
"The FTSE 100's ascent continues, helped today by a reversal
in the sterling strength... It is not hard to guess the cause of
this change, as Brexit talks drag on without any sign of
progress and the rhetoric from some European capitals becomes
increasingly more strident," said Chris Beauchamp, chief market
analyst at IG.
Brexit negotiations remained stuck with only weeks left for
Britain's transition agreement to expire. A senior British
minister said there was still a chance of a no-deal Brexit as
talks had snagged on fishing, governance rules and dispute
resolution.
The FTSE 100 had rallied more than 12% in November, marking
its best month in 31 years, as major global drugmakers announced
that their vaccine candidates were effective in preventing
COVID-19, sparking hopes of a faster economic rebound next year.
Britain became the first country to approve Pfizer's PFE.N
COVID-19 vaccine, in the race to begin the most crucial mass
inoculation programme in history with a shot tested in
wide-scale clinical trials. Coronavirus-related restrictions have hit business activity
and weighed on UK stock markets in recent weeks.
In company news, security group G4S GFS.L jumped 7.4%
after Canada's GardaWorld raised its offer for the British
company, valuing it at 3.68 billion pounds ($4.94 billion).
Stock Spirits Group STCK.L surged 11.7% after posting a
higher annual core profit and proposing a special dividend on
Wednesday as people stuck at home due to COVID-19 chose its
local brands.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.